1. What Happened at Biobijou?
Biobijou achieved remarkable sales of KRW 17.845 billion in the first half of 2025, marking an astounding 32.5% year-on-year growth. Notably, the company’s preliminary Q2 earnings surpassed market expectations, generating excitement among investors.
2. The Secret to Explosive Growth?
This growth is attributed to two key drivers: OEM business expansion and successful entry into overseas markets. Following the completion of its own production plant, Biobijou saw a significant increase in B2B sales. The company’s strategic expansion beyond China into North America, Southeast Asia, and Europe has solidified its global presence. Furthermore, a diversified product portfolio, including HA-based skin boosters, fillers, and cosmetics, along with continuous R&D investment, further strengthens Biobijou’s competitive edge.
3. What’s Next for Biobijou?
Through a rights offering in May 2025, Biobijou improved its financial structure and achieved a positive operating cash flow, establishing a stable foundation for growth. Future plans include the establishment of a second plant to expand production capacity, securing overseas certifications, and launching new products, all of which are expected to create additional growth momentum. However, increasing sales and administrative expenses and low production capacity utilization remain areas for improvement.
4. What Should Investors Do?
Biobijou’s 2025 half-year performance is a positive indicator for investors. Considering the current growth trajectory and future potential, Biobijou presents an attractive investment opportunity. However, before making any investment decisions, careful consideration should be given to factors such as H2 earnings trends, improvement in production capacity utilization, the success of global market expansion strategies, new product launches and R&D achievements, and the company’s ability to control sales and administrative expenses.
What is Biobijou’s core business?
Biobijou is a global aesthetics company that researches, manufactures, and sells hyaluronic acid (HA)-based skin boosters and fillers.
What was Biobijou’s sales growth rate for the first half of 2025?
It grew by 32.5% year-on-year.
What are Biobijou’s main growth drivers?
The main growth drivers are OEM business expansion, overseas market entry, a diversified product portfolio, and continuous R&D investment.
What should investors be aware of when considering investing in Biobijou?
Investors should consider factors such as increasing sales and administrative expenses, low production capacity utilization, exchange rate volatility, and intensifying competition.